Literature DB >> 29122321

Each procedure matters: threshold for surgeon volume to minimize complications and decrease cost associated with adrenalectomy.

Kevin L Anderson1, Samantha M Thomas2, Mohamed A Adam3, Lauren N Pontius1, Michael T Stang4, Randall P Scheri4, Sanziana A Roman4, Julie A Sosa5.   

Abstract

BACKGROUND: An association has been suggested between increasing surgeon volume and improved patient outcomes, but a threshold has not been defined for what constitutes a "high-volume" adrenal surgeon.
METHODS: Adult patients who underwent adrenalectomy by an identifiable surgeon between 1998-2009 were selected from the Healthcare Cost and Utilization Project National Inpatient Sample. Logistic regression modeling with restricted cubic splines was utilized to estimate the association between annual surgeon volume and complication rates in order to identify a volume threshold.
RESULTS: A total of 3,496 surgeons performed adrenalectomies on 6,712 patients; median annual surgeon volume was 1 case. After adjustment, the likelihood of experiencing a complication decreased with increasing annual surgeon volume up to 5.6 cases (95% confidence interval, 3.27-5.96). After adjustment, patients undergoing resection by low-volume surgeons (<6 cases/year) were more likely to experience complications (odds ratio 1.71, 95% confidence interval, 1.27-2.31, P = .005), have a greater hospital stay (relative risk 1.46, 95% confidence interval, 1.25-1.70, P = .003), and at increased cost (+26.2%, 95% confidence interval, 12.6-39.9, P = .02).
CONCLUSION: This study suggests that an annual threshold of surgeon volume (≥6 cases/year) that is associated with improved patient outcomes and decreased hospital cost. This volume threshold has implications for quality improvement, surgical referral and reimbursement, and surgical training.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 29122321     DOI: 10.1016/j.surg.2017.04.028

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  9 in total

Review 1.  Laparoscopic adrenalectomy.

Authors:  Marco Raffaelli; Carmela De Crea; Rocco Bellantone
Journal:  Gland Surg       Date:  2019-07

2.  Treatment at low-volume hospitals is associated with reduced short-term and long-term outcomes for patients with retroperitoneal sarcoma.

Authors:  Emily Z Keung; Yi-Ju Chiang; Janice N Cormier; Keila E Torres; Kelly K Hunt; Barry W Feig; Christina L Roland
Journal:  Cancer       Date:  2018-10-14       Impact factor: 6.860

Review 3.  Accreditation of endocrine surgery units.

Authors:  Thomas J Musholt; Robert Bränström; Reto Martin Kaderli; Nuria Muñoz Pérez; Marco Raffaelli; Michael J Stechman
Journal:  Langenbecks Arch Surg       Date:  2019-09-07       Impact factor: 3.445

4.  National perspective on hospital readmissions following adrenalectomy.

Authors:  Mohammed Hussein; Eman Toraih; Ahmed Mahmoud Fouad; Lauren Mueller; Alexander Blum; Zaid Al-Qurayshi; Jeffrey Borchardt; Emad Kandil
Journal:  Gland Surg       Date:  2022-06

5.  Racial Disparities of Adrenalectomy.

Authors:  Simon A Holoubek; Jessica Maxwell; Abbey L Fingeret
Journal:  J Endocr Soc       Date:  2020-08-07

Review 6.  Advances in adrenal tumors 2018.

Authors:  J Crona; F Beuschlein; K Pacak; B Skogseid
Journal:  Endocr Relat Cancer       Date:  2018-07       Impact factor: 5.678

Review 7.  Volume-outcome correlation in adrenal surgery-an ESES consensus statement.

Authors:  Radu Mihai; Gianluca Donatini; Oscar Vidal; Laurent Brunaud
Journal:  Langenbecks Arch Surg       Date:  2019-11-07       Impact factor: 3.445

8.  Optimal surgeon and hospital volume thresholds to reduce mortality and length of stay for CABG.

Authors:  Ying-Yi Chou; Juey-Jen Hwang; Yu-Chi Tung
Journal:  PLoS One       Date:  2021-04-14       Impact factor: 3.240

9.  Is Treatment at a High-volume Center Associated with an Improved Survival for Primary Malignant Bone Tumors?

Authors:  Azeem Tariq Malik; John H Alexander; Safdar N Khan; Thomas J Scharschmidt
Journal:  Clin Orthop Relat Res       Date:  2020-03       Impact factor: 4.755

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.